Speaker Series – A new C5 inhibitor treatment for atypical haemolytic uraemic syndrome

We’re delighted to add a summary of a webinar featuring international speaker Dr Enrique Morales (Madrid, Spain), and chaired by Associate Professor Nikky Isbel (Queensland).

The discussion covers management of atypical haemolytic uraemic syndrome with ravulizumab, efficacy and safety data, and real-world cases illustrating different aHUS clinical scenarios.

 

Please login below to download this issue (PDF)

Subscribe